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summary
dysphagia following cardiac surgery is a frequently encountered problem, being most 
commonly due to the sternotomy incision and/or prolonged intubation. Oesophageal 
candidiasis is an increasing problem that is usually associated with immunosuppression 
or immunodeficiency. We report a 59 years age, immunocompetent lady whom had 
developed dysphagia and odynophagia following open cardiac surgery and long 
term course of antibiotics. diagnosis of candida oesophagitis was established after 
radiological, endoscopic and microbiological evidence, and successful treatment 
with combined topical and systemic antifungal therapy was achieved. possibility of 
immunodeficiency was excluded. We believe that this lady developed oesophageal 
candidiasis due to a long term course of broad spectrum antibiotics. we discuss the 
various diagnostic modalities and treatment options.
intrOductiOn
Dysphagia is well known to complicate cardiac 
operations. It is most commonly related to 
median sternotomy and intra-operative or post-
operative interventions, such as transesophageal 
echocardiography and/or endotracheal intubation 
(1). Candida oesophagitis is an increasingly 
recognised problem which presents with dysphagia 
and odynophagia, but it is usually associated with 
immunodeficiency or immunosuppression, and it is 
not usually suspected following cardiac surgery in 
an immunocompetent adult (3, 4). 
In this article, we report an immunocompetent lady 
who developed Candida oesophagitis following open 
cardiac surgery and a course of antibiotics. 
casE rEpOrt
Our patient, a 59 year old female, with severe 
mitral stenosis and huge left atrial thrombus. 
She is not known to have diabetes or HIV or any 
other immunodeficiency conditions, and she was 
not on any immunosuppressant medications. She 
underwent open mitral valvotomy and removal 
of the thrombus through a median sternotomy 
incision. She was covered with prophylactic pre 
and post-operative antibiotics. On the fifth post-
operative day, she developed severe chest infection, 
for which, a potent cephalosporin was prescribed 
and continued for two weeks, and then discharged 
in a good condition. Three weeks after discharge, 
she came with dysphagia and odynophagia. Barium 
swallow showed multiple large plaque like lesions, 
cobblestone appearance of oesophageal mucosa and 
a pseudo-membrane mimicking a double lumen 
oesophagus, features suggestive of Candida infection. 
Endoscopy showed severe hyperemic mucosa, 
patchy ulcerations, whitish streaks and stricture of 
the middle third of the oesophagus. Oesophageal 
brush was taken for culture and sensitivity and the 
results proved Candida albicans infection. Possibility 
of immunodeficiency was excluded by normal 
Full blood count (FBC), Renal Function Test,Liver 
function test (LFT),Blood Sugar, CD4 and negative 
HIV tests. She was successfully treated with oral 
nystatin and intravenous Amphoteracin B, with 
repeated endoscopic oesophagial dilatations. She 
was discharged after one month. Her follow-up 
showed complete resolution of the stricture and she 
was asymptomatic. 
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Barrium study of the oesophagus in a patient with Candida Oesophagitis. (A) Before treatment showing 
plaque like lesions in a linear pattern (arrows), separated by normal mucosa. (B) After treatment showing 
residual stricture (arrow).
discussiOn
Swallowing difficulties, and subsequent pulmonary 
aspiration, is a common problem, being observed 
in as many as 15% of patients in acute care facilities 
(5).Patients undergoing cardiac surgery, due to their 
complex risk profile, are especially more vulnerable 
to sustain post-operative morbidities, including 
dysphagia (6-9).In one study, swallowing dysfunction 
was found in 4% of patients undergoing cardiac 
surgery, with significant association to the post-
operative outcome and morbidity including post-
operative pneumonia, need for tracheostomy, and 
increased length of hospital and ICU admission (1). 
The main risk factors for dysphagia following cardiac 
surgery are prolonged endotracheal intubation, the 
use of transoesophageal echocardiography (TOE) 
and the need for tracheostomy tube (1, 2, 10, 11). 
In our patient, intra-operative transoesophageal 
echocardiography was not performed, and she did not 
need prolonged intubation or tracheostomy tube, so 
we thought of other potential causes of dysphagia and 
odynophagia.Candida oesophagitis is an increasingly 
recognised condition in the past two decades (13). This 
systemic mycosis is mainly associated with conditions 
of immunodeficiency or immunosuppression, such 
as AIDS, cancer, and prolonged steroid therapy 
(14, 15). Other possible predisposing factor is local 
oesophageal stasis caused by severe oesophageal 
motility disorders such as achalasia and scleroderma 
(18). All these predisposing factors were excluded 
in our patient and the immunological workup was 
normal. The only possible predisposing factor in our 
case was the use of potent antibiotics for her severe 
chest infection.
 Oesophageal candidiasis in immunocompetent 
adults is an area of extensive research. There is an 
evidence of some alterations in cellular immunity 
in some patients. These alterations include low CD4 
and CD8 lymphocyte count and abnormal Yeast 
phagocytosis and neutrophil chemotaxis (43).Another, 
and contradicting, study about the immunological 
profile of seven patients with oesophageal candidiasis 
had shown no cellular immunity changes including 
immunoglobulins,complement and lymphocytes 
population in most of the patients examined, with 
severe IgG hypogammaglobulinemia in only one 
patient (44). Candida oesophagitis due to antibiotic 
therapy has been reported only in few articles (4, 12, 
15, 32). Bacterial commensals in the gut inhibits fungal 
growth and colonisation, thus protect against candidal 
infection, and this inhibitory effect is eliminated by 
administration of potent antibiotics (3, 33).
 Diagnosis of oesophageal candidiasis remains 
challenging and involves clinical, radiologic and 
endoscopic visualisation, but the gold standard is the 
microbiological identification of the organism from an 
oesophageal brushings or biopsy, with determination 
of the causative species and it is drug susceptibility 
(16, 17). Although Candida albicans is still the most 
common species, there is a recently observed shift 
towards other non-albicans species such as C. glabrata 
and C. krusei (31). Double contrast barium study is 
useful and the main finding is the discrete ,linear 
plaquelike lesions separated by normal mucosa, 
but this needs to be carefully differentiated from the 
resembling rounded plaque  like lesions of Glycogenic 
acanthosis, a  condition that usually affect elderly 
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people (19-21).These plaques may coalesce in severe 
disease to form the classical cobblestone appearance 
(24). The ability of double contrast barium study to 
identify these plaque  like lesions gives it a sensitivity 
of 90% (19, 22).Endoscopy plays an important role 
in the diagnosis and it allows direct visualisation of 
the characteristic candidal lesions, as well as taking 
a biopsy or brushings for mycological identification 
(23). In our patient, the double contrast barium study 
findings were consistent with the above mentioned 
literature, with typical and large filling defects 
arranged in a longitudinal pattern and separated 
by normal mucosa.Moreover,a pseudomembrane 
appearance giving the picture of double lumen is 
observed, a finding not commonly reported with 
oesophageal candidiasis.
 Early treatment with the appropriate antifungal 
therapy is essential to reduce morbidity and mortality 
(16, 30). The aim of treatment is the elimination 
of symptoms and signs of the disease, as well as 
prevention of future recurrences (25). Generally, 
topical therapy is ineffective for oesophageal 
candidiasis, whereas Azoles (fluconazole or 
itraconazole) or intravenous amphotericin B are 
effective (25). Resistance to fluconazole is an 
emerging problem (26). New antifungal agents like 
echinocandin are proved effective for azole resistant 
cases, better tolerated and with less adverse effects 
than amphotericin B (27-29).The choice of the initial 
therapy depends on the condition of the patient. 
In non-leucopenic patients’ initial therapy with 
fluconazole or one of the three approved echinocandin 
compound is appropriate, liposomal amphotericin B 
and voriconazole are second line options because of 
their adverse effect profile (17).On the other hand, 
echinocandins or liposomal amphotericin B are 
recommended as first line in those with leucopenia 
(17).Due to the high risk profile of our patient and 
the no availability and cost of echinocandin, we 
preferred to give intravenous amphotericin B as a 
practical option, and the response was excellent.
 One aspect of controlling Candida infections is the 
identification of high risk patients for consideration of 
prophylactic or empirical therapy, through validated 
risk assessment scoring tools (34-39). However, 
this issue of prophylactic antifungal therapy is 
still controversial and the data are contradicting. 
In one study, the use of prophylactic antifungal 
therapy was associated with reduced proportion of 
candidaemia and other fungal infections, reduced 
need for amphotericin B for systemic infections, 
a trend towards reduction in hospital morbidity, 
with no significant contribution to the fluconazole 
resistance (40). On the other hand, there are 
significant data on the a clear correlation between 
fluconazole use control and decreasing incidence of 
non-albicans candidaemia (41).Recently, there are 
some promising results on the use of monoclonal 
antibodies, like Mycograb (a human recombinant 
monoclonal antibody that inhibits heat shock protein 
90) , combined to antifungal medications for the 
immunoprophylaxis of candidal infections in high 
risk groups, but these are still in the stage of in vitro 
and animal experiments (42).
In conclusion, candida oesophagitis should be 
suspected as a cause of dysphagia following 
cardiac surgery and antibiotics use, even in 
immunocompetent patients. Diagnosis needs clinical, 
radiological, endoscopic and microbiological tests, 
and treatment with combined topical and systemic 
antifungal is effective. More research and clear 
consensus is needed to guide the use of prophylactic 
antifungal medications for high risk patients.
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